Emphysema did not significantly affect the response to systemic therapy in patients with severe asthma, according to a recent retrospective study. Early improvement was linked to lower baseline FEV1 ...

Head of “Living With”, Mariel Metcalfe, discusses the nature of severe asthma and severe eosinophilic asthma ... lung tissue and mucus, meaning the whole respiratory tract suffers from ...

Macrolides reduce exacerbations when added to inhaled therapy in severe asthma. However, there is little published evidence for effectiveness in patients treated with biologics. We conducted a ...

TUESDAY, Dec. 10, 2024 (HealthDay News) -- Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), according to a ...

No fatal adverse events occurred, and benralizumab was well tolerated. HealthDay News — Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive ...

(HealthDay News) — Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), according to a study published online Nov.

The first new treatment for asthma attacks in 50 years has been hailed as a "game-changer" by doctors and patients. A clinical trial of the drug benralizumab showed it was far more effective than ...

Asthma causes your airways to constrict, and humid air can make it more difficult to breathe. You can keep humidity at reasonable levels indoors and take steps to protect yourself outside in humid ...

TUESDAY, Dec. 10, 2024 (HealthDay News) — Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), according to a ...

Asthma is the most common chronic disease of childhood and, in the latter part of the 20th century, reached epidemic proportions. Asthma is generally believed to result from gene-environment ...